Copyright
©2011 Baishideng Publishing Group Co.
World J Hepatol. Jan 27, 2011; 3(1): 24-30
Published online Jan 27, 2011. doi: 10.4254/wjh.v3.i1.24
Published online Jan 27, 2011. doi: 10.4254/wjh.v3.i1.24
Table 1 Distribution of hepatocellular carcinoma cases and control according to studied risk factors
| Risk factor | HCC cases (n = 164) | Controls (n = 250) | Odds ratio |
| NIDD | 18.00% (n = 139) | 2.70% (n = 225) | 8.0 (3.1 - 20.0) |
| HBV status | |||
| HBsAg +/anti-HBc + | 17.90% | 4.00% | 7.2 (3.2 - 16.1) |
| Anti-HBc + alone | 15.40% | 11.50% | 2.1 (1.1 - 4.0) |
| Anti-HBc +/anti-HBs + | 23.50% | 14.60% | 2.5 (1.5 - 4.4) |
| Anti-HCV | |||
| Anti-HCV + | 60.00% | 4.40% | 32.0 (15.8 - 65.0) |
- Citation: Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AEE, Mestiri H, Benazzouz M, Khalfallah T, Afifi R, Elkihal L, Berkane S, Marchio A, Debzi N, Dejean A, Pineau P, Triki H, Benjelloun S. First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 2011; 3(1): 24-30
- URL: https://www.wjgnet.com/1948-5182/full/v3/i1/24.htm
- DOI: https://dx.doi.org/10.4254/wjh.v3.i1.24